Celling Spine acquired all assets of Link Spine, a subsidiary of Link Orthopedics of Germany, and will develop a spinal fusion system focused on facet fixation and minimally invasive surgery to complement its own cell-based biologic portfolio. Celling's products collect, process and deliver autologous cells to the patient at the point of care.
Link Spine's midline system features three platforms: FacetLink, CorticalLink and Vertbralink, and is integrated to minimize the number of trays required and to allow intra-operative flexibility regarding fixation.
Dr. Christopher Chaput, a lead designer for Link's system, will help Celling with their development strategy. He noted that the platform is able to address a range from minimally invasive fusion up to more maximally open procedures, and improves the surgeons' ability to perform less invasive surgery from a traditional midline approach using incisions that are as small or smaller than what is considered minimally invasive.
The combination of increased options for "graded" fixation and implants that complement cell-based healing may be particularly attractive in an ambulatory surgical center or short-stay setting.
Source: Celling Biosciences